Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# Robots file User-agent: * Allow: / Disallow: /-_-/api/ Sitemap: |
Title | ATI |
Description | Acclivity Technologies Inc. About us News Contact us News Contact us Acclivity Technologies, Inc. (ATI) is a discovery to preclinical health technologies company located in North Car |
Keywords | N/A |
WebSite | acclivitytechnologies.com |
Host IP | 217.160.0.96 |
Location | Germany |
Site | Rank |
US$764
Last updated: 2023-05-20 07:21:11
acclivitytechnologies.com has Semrush global rank of 0. acclivitytechnologies.com has an estimated worth of US$ 764, based on its estimated Ads revenue. acclivitytechnologies.com receives approximately 88 unique visitors each day. Its web server is located in Germany, with IP address 217.160.0.96. According to SiteAdvisor, acclivitytechnologies.com is safe to visit. |
Purchase/Sale Value | US$764 |
Daily Ads Revenue | US$0 |
Monthly Ads Revenue | US$21 |
Yearly Ads Revenue | US$254 |
Daily Unique Visitors | 5 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
acclivitytechnologies.com. 3599 | A | acclivitytechnologies.com. 3599 | IP: 217.160.0.96 |
acclivitytechnologies.com. 3599 | AAAA | acclivitytechnologies.com. 3599 | IPV6: 2001:8d8:100f:f000::200 |
acclivitytechnologies.com. 86400 IN | NS | NS Record: ns1028.ui-dns.biz. | |
acclivitytechnologies.com. 86400 IN | NS | NS Record: ns1019.ui-dns.com. | |
acclivitytechnologies.com. 86400 IN | NS | NS Record: ns1038.ui-dns.de. | |
acclivitytechnologies.com. 86400 IN | NS | NS Record: ns1020.ui-dns.org. | |
acclivitytechnologies.com. 3600 | MX | acclivitytechnologies.com. 3600 | MX Record: 10 mx00.ionos.com. |
acclivitytechnologies.com. 3600 | MX | acclivitytechnologies.com. 3600 | MX Record: 10 mx01.ionos.com. |
About us News Contact us News Contact us Acclivity Technologies, Inc. (ATI) is a discovery to preclinical health technologies company located in North Carolina. ATI’s lead drug candidate, ATI-0019, is a novel small molecule for a known atherosclerotic and ischemic disease target not previously known to be druggable by small molecules. Activation of this target reverses cardiovascular disease driver processes, including endothelial dysfunction, endothelial damage and loss of vasculature, inflammatory cell response, smooth muscle cell proliferation and migration, and platelet activation. We are testing and improving the pharmacological properties of ATI-0019, building a library of related compounds, and conducting in vitro and in vivo studies to establish the utility of ATI-0019 to treat our lead disease indication, peripheral artery disease, and its manifestations including intermittent claudication, critical limb ischemia, non-healing wounds, and diabetic foot. ATI-0019 and its |
HTTP/1.1 301 Moved Permanently Content-Type: text/html Connection: keep-alive Keep-Alive: timeout=15 Date: Sun, 22 Jan 2023 08:40:05 GMT Server: Apache Cache-Control: max-age=3600 Location: https://www.acclivitytechnologies.com HTTP/2 200 content-type: text/html content-length: 91523 server: nginx date: Sun, 22 Jan 2023 08:40:05 GMT vary: Accept-Encoding etag: "f5c00e8ec68e04525d833386e024462a" x-amz-version-id: null cache-control: no-cache last-modified: Sat, 21 Jan 2023 16:24:23 GMT x-cache: MISS from itproxy.1and1.org x-cache-lookup: MISS from itproxy.1and1.org:3128 via: 1.1 itproxy.1and1.org (squid/4.15) x-server: itproxy-live-de-kae-bs01 accept-ranges: bytes strict-transport-security: max-age=15768000 |